Health Care

Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke -- Head of Investor Relations Christopher…

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net…

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…

AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for…

Ventas Inc (NYSE: VTR) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: BJ Grant -- Senior Vice President-Investor Relations Debra A.…

IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs -- Senior Vice President - Investor…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…

Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch -- Executive Director, Investor Relations, and Corporate…

AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett -- Vice President Global Head of Investor…

Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns -- Director, Investor Relations David…